Healthcare provider profile · identity verified

Kevin Andrew Gallagher, MD

Family Practice · WARRENSBURG, NY · NPI 1194778464

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Shingrix	Varicella-Zoster Ge/As01b/Pf	10333	7558
Arexvy	Rsvpref3 Antigen/As01e/Pf	7950	7919
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	4245	4231
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	2603	2600
Twinrix	Hepatitis A And B Vaccine/Pf	1941	1119
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	827	824
Atorvastatin Calcium	Atorvastatin Calcium	390	123
Lisinopril	Lisinopril	179	56
Havrix	Hepatitis A Virus Vaccine/Pf	162	137
Levothyroxine Sodium	Levothyroxine Sodium	156	40
Omeprazole	Omeprazole	155	47
Losartan Potassium	Losartan Potassium	147	44
Amlodipine Besylate	Amlodipine Besylate	140	46
Gabapentin	Gabapentin	134	26
Metformin Hcl	Metformin Hcl	127	35
Metoprolol Succinate	Metoprolol Succinate	112	36
Tamsulosin Hcl	Tamsulosin Hcl	108	33
Pregabalin	Pregabalin	100	21
Rosuvastatin Calcium	Rosuvastatin Calcium	97	33
Ozempic	Semaglutide	92	17
Hydrochlorothiazide	Hydrochlorothiazide	91	30
Fluticasone Propionate	Fluticasone Propionate	90	34
Morphine Sulfate Er	Morphine Sulfate	89	suppressed
Simvastatin	Simvastatin	78	27
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	76	14
Fluoxetine Hcl	Fluoxetine Hcl	74	13
Albuterol Sulfate Hfa	Albuterol Sulfate	70	24
Tramadol Hcl	Tramadol Hcl	69	15
Trazodone Hcl	Trazodone Hcl	69	18
Duloxetine Hcl	Duloxetine Hcl	68	17
Montelukast Sodium	Montelukast Sodium	64	21
Zolpidem Tartrate	Zolpidem Tartrate	62	12
Alprazolam	Alprazolam	60	14
Celecoxib	Celecoxib	60	16
Clopidogrel	Clopidogrel Bisulfate	60	16
Famotidine	Famotidine	58	18
Sertraline Hcl	Sertraline Hcl	56	13
Hydroxyzine Hcl	Hydroxyzine Hcl	53	13
Metformin Hcl Er	Metformin Hcl	51	18
Prednisone	Prednisone	51	38
Clonazepam	Clonazepam	49	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	49	suppressed
Furosemide	Furosemide	48	17
Mounjaro	Tirzepatide	48	11
Spironolactone	Spironolactone	44	11
Bupropion Xl	Bupropion Hcl	43	suppressed
Diclofenac Sodium	Diclofenac Sodium	43	15
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	43	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	39	21
Jardiance	Empagliflozin	38	suppressed
Trulicity	Dulaglutide	38	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	37	11
Alendronate Sodium	Alendronate Sodium	36	suppressed
Allopurinol	Allopurinol	36	14
Potassium Chloride	Potassium Chloride	36	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	35	suppressed
M-M-R Ii Vaccine	Measles,mumps,rubella Vacc/Pf	32	28
Finasteride	Finasteride	31	suppressed
Atenolol	Atenolol	30	suppressed
Eliquis	Apixaban	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Methylprednisolone	Methylprednisolone	28	22
Metoprolol Tartrate	Metoprolol Tartrate	28	12
Doxycycline Hyclate	Doxycycline Hyclate	27	22
Ibuprofen	Ibuprofen	26	suppressed
Menquadfi	Mening Vac A,c,y,w135,c-Tet/Pf	26	26
Synthroid	Levothyroxine Sodium	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	25	suppressed
Ondansetron Odt	Ondansetron	25	14
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Gardasil 9	Hpv Vaccine 9-Valent/Pf	22	13
Mirtazapine	Mirtazapine	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Topiramate	Topiramate	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Irbesartan	Irbesartan	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Ramipril	Ramipril	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Vaqta	Hepatitis A Virus Vaccine/Pf	21	18
Meloxicam	Meloxicam	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	20	suppressed
Priorix	Measles,mumps,rubella Vacc/Pf	20	20
Colchicine	Colchicine	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Ibandronate Sodium	Ibandronate Sodium	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Carvedilol	Carvedilol	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Tiotropium Bromide	Tiotropium Bromide	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Linzess	Linaclotide	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Testosterone	Testosterone	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Naproxen	Naproxen	12	suppressed
Silodosin	Silodosin	12	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	12	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Dilt-Xr	Diltiazem Hcl	11	suppressed
Glipizide	Glipizide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error